Expression of the high-risk human papillomavirus type 18 and 45 E7 oncoproteins in cervical carcinoma biopsies

Journal of General Virology

Volumn 86, Issue 12, 2005, Pages 3235-3241

  Fiedler, Marc ^a,b   Ressler, Sigrun ^a,b   Campo Fernández, Beatriz ^a,b   Laich, Andreas ^a,c   Jansen, Lars ^d   Widschwendter, Andreas ^e   Viertler, Hans Peter ^b   Bacher, Nicole ^a,b   Morandell, Dieter ^a,b   Müller Holzner, Elisabeth ^e   Dürst, Matthias ^d   Jansen Dürr, Pidder ^b   Zwerschke, Werner ^a,b  

^a TYROLEAN CANCER RESEARCH INSTITUTE   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c Amynon BioTech   (Austria)

^d FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^e UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN ANTIBODY; PROTEIN E7;

ARTICLE; CANCER RISK; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEROPREVALENCE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

ANTIBODIES, VIRAL; BIOPSY; BLOTTING, WESTERN; DNA-BINDING PROTEINS; FEMALE; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRUS;

EID: 28044453522     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81390-0     Document Type: Article

References (24)

1. Barbosa, M. S. & Schlegel, R. (1989). The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4, 1529-1532.
2. Bosch, F. X., Lorincz, A., Muñoz, N., Meijer, C. J. L. M. & Shah, K. V. (2002). The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55, 244-265.
3. Crook, T., Morgenstern, J. P., Crawford, L. & Banks, L. (1989). Continued expression of HPV-16 E7 protein is required for maintenance of the transformed phenotype of cells co-transformed by HPV-16 plus EJ-ras. EMBO J 8, 513-519.
4. Dyson, N., Howley, P. M., Munger, K. & Harlow, E. (1989). The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243, 934-937.
5. Fiedler, M., Müller-Holzner, E., Viertler, H.-P., Widschwendter, A., Laich, A., Pfister, G., Spoden, G. A., Jansen-Dürr, P. & Zwerschke, W. (2004). High level HPV-16 E7 oncoprotein expression correlates with reduced pRb-levels in cervical biopsies. FASEB J 18, 1120-1122.
6. Geisbill, J., Osmers, U. & Dürst, M. (1997). Detection and characterization of human papillomavirus type 45 DNA in the cervical carcinoma cell line MS751. J Gen Virol 78, 655-658.
7. Hudson, J. B., Bedell, M. A., McCance, D. J. & Laiminis, L. A. (1990). Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J Virol 64, 519-526.
8. Jeon, S., Allen-Hoffmann, B. L. & Lambert, P. F. (1995). Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69, 2989-2997.
9. INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92, 276-284.
10. Lowy, D. R. & Howley, P. M. (2001). Papillomaviruses. In Field's Virology, 4th edn, pp. 2231-2264. Edited by D. M. Knipe & P. M. Howley. Philadelphia, PA: Lippincott Williams & Wilkins.
11. Luft, F., Klaes, R., Nees, M., Dürst, M., Heilmann, V., Melsheimer, P. & von Knebel Doeberitz, M. (2001). Detection of integrated papillomavirus sequences by ligation-mediated PCR (DIPS-PCR) and molecular characterization in cervical cancer cells. Int J Cancer 92, 9-17.
12. Mannhardt, B., Weinzimer, S., Wagner, M., Fiedler, M., Cohen, P., Jansen-Dürr, P. & Zwerschke, W. (2000). Human papillomavirus type 16 E7 oncoprotein binds and inactivates growth-inhibitory insulin-like growth factor binding protein 3. Mol Cell Biol 20, 6483-6495.
13. Münger, K. & Howley, P. M. (2002). Human papillomavirus immortalization and transformation functions. Virus Res 89, 213-228.
14. Münger, K., Phelps, W. C., Bubb, V., Howley, P. M. & Schlegel, R. (1989). The E6 and E7 genes of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63, 4417-4421.
15. Muñoz, N. (2000). Human papillomavirus and cancer: the epidemiological evidence. J Clin Virol 19, 1-5.
16. Pisani, P., Bray, F. & Parkin, D. M. (2002). Estimates of the worldwide prevalence of cancer for 25 sites in the adult population. Int J Cancer 97, 72-81.
17. Sano, T., Oyama, T., Kashiwabara, K., Fukuda, T. & Nakajima, T. (1998). Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 153, 1741-1748.
18. Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A. & zur Hausen, H. (1985). Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314, 111-114.
19. Smotkin, D. & Wettstein, F. O. (1987). The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol 61, 1686-1689.
20. Ullman, C. G., Haris, P. I., Galloway, D. A., Emery, V. C. & Perkins, S. J. (1996). Predicted α-helix/β-sheet secondary structures for the zinc-binding motifs of human papillomavirus E7 and E6 proteins by consensus prediction averaging and spectroscopic studies of E7. Biochem J 319, 229-239.
21. von Knebel Doeberitz, M. (2002). New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections. Eur J Cancer 38, 2229-2242.
22. Walboomers, J. M. M., Jacobs, M. V., Manos, M. M. & 7 other authors (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189, 12-19.
23. zur Hausen, H. (2000). Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92, 690-698.
24. Zwerschke, W. & Jansen-Dürr, P. (2000). Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv Cancer Res 78, 1-29.